Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
 | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
 |  |  |  | ||||||
| MAP2K1 | BRAF | BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase | 6.08E3 | Evidence |
O
|
||||
| MAP2K1 | RAF1 | RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase | 3.26E3 | Evidence |
O
|
||||
| MAP2K1 | AKT1 | AKT1, PKB, RAC: RAC-alpha serine/threonine-protein kinase | 32.80 | Evidence | |||||
| MAP2K1 | DUSP1 | DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 | 31.20 | Evidence | |||||
| MAP2K1 | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 30.00 | Evidence | |||||
| MAP2K1 | DOCK2 | DOCK2, KIAA0209: Dedicator of cytokinesis protein 2 | 27.80 | Evidence | |||||
| MAP2K1 | MAPK1 | MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 | 27.80 | Evidence |
O
|
||||
| MAP2K1 | JAK2 | JAK2: Tyrosine-protein kinase JAK2 | 25.00 | Evidence | |||||
| MAP2K1 | VAV1 | VAV1, VAV: Proto-oncogene vav | 25.00 | Evidence | |||||
| MAP2K1 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 23.70 | Evidence | |||||
| MAP2K1 | DUSP6 | DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 | 20.50 | Evidence | |||||
| MAP2K1 | JAK1 | 20.50 | Evidence | ||||||
| MAP2K1 | PRKCZ | PRKCZ, PKC2: Protein kinase C zeta type | 20.40 | Evidence |
|
||||
| MAP2K1 | NRAS | NRAS, HRAS1: GTPase NRas precursor | 20.20 | Evidence | |||||
| MAP2K1 | YWHAB | YWHAB: 14-3-3 protein beta/alpha | 17.90 | Evidence | |||||
| MAP2K1 | CDC25A | CDC25A: M-phase inducer phosphatase 1 | 17.60 | Evidence | |||||
| MAP2K1 | DUSP16 | DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 | 17.60 | Evidence | |||||
| MAP2K1 | PARD6A | PARD6A, PAR6A: Partitioning defective 6 homolog alpha | 17.60 | Evidence | |||||
| MAP2K1 | SPTBN1 | SPTBN1, SPTB2: Spectrin beta chain, brain 1 | 17.60 | Evidence | |||||
| MAP2K1 | PDPK1 | PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 | 17.60 | Evidence | |||||
| MAP2K1 | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 17.30 | Evidence | |||||
| MAP2K1 | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 17.30 | Evidence | |||||
| MAP2K1 | IRAK1 | IRAK1, IRAK: Interleukin-1 receptor-associated kinase 1 | 16.50 | Evidence | |||||
| MAP2K1 | HSP90AA1 | Hsp89-alpha-delta-N | 16.50 | Evidence | |||||
| MAP2K1 | MAPK3 | MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 | 15.70 | Evidence |
O
|
||||
| MAP2K1 | YWHAZ | YWHAZ: 14-3-3 protein zeta/delta | 15.40 | Evidence | |||||
| MAP2K1 | FRS3 | FRS3: Fibroblast growth factor receptor substrate 3 | 15.30 | Evidence | |||||
| MAP2K1 | RB1 | RB1: Retinoblastoma-associated protein | 15.10 | Evidence | |||||
| MAP2K1 | CFLAR | CFLAR, CASH, CASP8AP1, CLARP, MRIT: CASP8 and FADD-like apoptosis regulator prec | 15.10 | Evidence | |||||
| MAP2K1 | DUSP3 | DUSP3, VHR: Dual specificity protein phosphatase 3 | 13.80 | Evidence | |||||
| MAP2K1 | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 13.40 | Evidence | |||||